Unknown

Dataset Information

0

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.


ABSTRACT:

Objective

Mutations in the glucocerebrosidase gene (GBA) represent a significant risk factor for developing Parkinson disease (PD). We investigated the enzymatic activity of glucocerebrosidase (GCase) in PD brains carrying heterozygote GBA mutations (PD+GBA) and sporadic PD brains.

Methods

GCase activity was measured using a fluorescent assay in cerebellum, frontal cortex, putamen, amygdala, and substantia nigra of PD+GBA (n = 9-14) and sporadic PD brains (n = 12-14). Protein expression of GCase and other lysosomal proteins was determined by western blotting. The relation between GCase, ?-synuclein, and mitochondria function was also investigated in vitro.

Results

A significant decrease in GCase activity was observed in all PD+GBA brain areas except the frontal cortex. The greatest deficiency was in the substantia nigra (58% decrease; p < 0.01). GCase activity was also significantly decreased in the substantia nigra (33% decrease; p < 0.05) and cerebellum (24% decrease; p < 0.05) of sporadic PD brains. GCase protein expression was lower in PD+GBA and PD brains, whereas increased C/EBP homologous protein and binding immunoglobulin protein levels indicated that the unfolded protein response was activated. Elevated ?-synuclein levels or PTEN-induced putative kinase 1 deficiency in cultured cells had a significant effect on GCase protein levels.

Interpretation

GCase deficiency in PD brains with GBA mutations is a combination of decreased catalytic activity and reduced protein levels. This is most pronounced in the substantia nigra. Biochemical changes involved in PD pathogenesis affect wild-type GCase protein expression in vitro, and these could be contributing factors to the GCase deficiency observed in sporadic PD brains.

SUBMITTER: Gegg ME 

PROVIDER: S-EPMC3638323 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.

Gegg Matthew E ME   Burke Derek D   Heales Simon J R SJ   Cooper J Mark JM   Hardy John J   Wood Nicholas W NW   Schapira Anthony H V AH  

Annals of neurology 20120901 3


<h4>Objective</h4>Mutations in the glucocerebrosidase gene (GBA) represent a significant risk factor for developing Parkinson disease (PD). We investigated the enzymatic activity of glucocerebrosidase (GCase) in PD brains carrying heterozygote GBA mutations (PD+GBA) and sporadic PD brains.<h4>Methods</h4>GCase activity was measured using a fluorescent assay in cerebellum, frontal cortex, putamen, amygdala, and substantia nigra of PD+GBA (n = 9-14) and sporadic PD brains (n = 12-14). Protein expr  ...[more]

Similar Datasets

| S-EPMC5121427 | biostudies-other
| S-EPMC5751707 | biostudies-literature
| S-EPMC2677508 | biostudies-literature
| S-EPMC6438360 | biostudies-literature
| S-EPMC8013050 | biostudies-literature
| S-EPMC3716474 | biostudies-literature
| S-EPMC10418497 | biostudies-literature
2021-11-03 | GSE187012 | GEO